Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALB | P02768 | 1/20 | 0.51 |
| ▸ | NAALAD2 | Q9Y3Q0 | 10/20 | 0.47 |
| ▸ | FOLH1 | Q04609 | 8/20 | 0.38 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.36 |
| ▸ | FTO | Q9C0B1 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24910527 | 0.78 | NAALAD2 (0.66) | ALBNAALAD2FOLH1NR1H2FTO | |
| SCHEMBL24910738 | 0.74 | NAALAD2 (0.63) | ALBNAALAD2FOLH1NR1H2FTO | |
| SCHEMBL13286293 | 0.68 | ALB (1.00) | ALBNAALAD2FTO | |
| SCHEMBL12946586 | 0.67 | ALB (0.72) | ALBNAALAD2FOLH1NR1H2FTO | |
| SCHEMBL13286294 | 0.67 | ALB (0.78) | ALBNAALAD2FOLH1NR1H2FTO | |
| SCHEMBL20341448 | 0.66 | GSTP1 (0.49) | ALBNAALAD2FOLH1 | |
| SCHEMBL25613623 | 0.66 | ALB (0.54) | ALBNAALAD2NR1H2FTO | |
| SCHEMBL12946728 | 0.66 | ALB (0.81) | ALBNAALAD2FOLH1FTO | |
| SCHEMBL30311220 | 0.65 | ALB (0.59) | ALBNAALAD2FOLH1FTO | |
| SCHEMBL12914887 | 0.65 | ALB (0.62) | ALBNAALAD2FOLH1FTO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230016265-A1 | PSMA-TARGETING IMAGING AGENTS | THE CLEVELAND CLINIC FOUNDATION | 2023-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230016265-A1 | PSMA-TARGETING IMAGING AGENTS | FOLH1, PSMA1, PSMA2 | ALB 405/4885NAALAD2 92/4885FOLH1 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.